HydroxychloroquineStevens-Johnson syndrome following an off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82415-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：135 / 135

相关论文

共 50 条

[1] HydroxychloroquineStevens-Johnson syndrome: case report
Reactions Weekly, 2018, 1719 (1) : 117 - 117
[2] HydroxychloroquineStevens-johnson syndrome: case report
Reactions Weekly, 2024, 2025 (1) : 211 - 211
[3] HydroxychloroquineStevens-Johnson syndrome
Reactions Weekly, 2024, 2001 (1) : 161 - 161
[4] MizoribineFanconi syndrome following off-label treatment: case report
Reactions Weekly, 2021, 1838 (1) : 341 - 341
[5] CobimetinibDropped head syndrome following off-label treatment: case report
Reactions Weekly, 2019, 1782 (1) : 110 - 110
[6] HydroxychloroquineHepatotoxicity following off-label treatment: case report
Reactions Weekly, 2020, 1812 (1) : 148 - 148
[7] PembrolizumabNeutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1851 (1) : 288 - 288
[8] RivoceranibHaemafecia following off-label treatment: case report
Reactions Weekly, 2018, 1721 (1) : 263 - 263
[9] BexaroteneTransaminitis following an off-label treatment: case report
Reactions Weekly, 2019, 1741 (1) : 59 - 59
[10] VenetoclaxNeutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1849 (1) : 412 - 412

← 1 2 3 4 5 →